Salarius Pharmaceuticals Statistics
Total Valuation
SLRX has a market cap or net worth of $2.07 million. The enterprise value is -$937,561.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
| Earnings Date | Nov 14, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
SLRX has 1.44 million shares outstanding. The number of shares has increased by 69.10% in one year.
| Current Share Class | 1.44M |
| Shares Outstanding | 1.44M |
| Shares Change (YoY) | +69.10% |
| Shares Change (QoQ) | +14.51% |
| Owned by Insiders (%) | 2.52% |
| Owned by Institutions (%) | 0.71% |
| Float | 1.40M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.69 |
| P/TBV Ratio | 0.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.09, with a Debt / Equity ratio of 0.11.
| Current Ratio | 4.09 |
| Quick Ratio | 3.51 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -110.87% and return on invested capital (ROIC) is -66.56%.
| Return on Equity (ROE) | -110.87% |
| Return on Assets (ROA) | -53.17% |
| Return on Capital (ROIC) | -66.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$2.50M |
| Employee Count | 2 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.85% in the last 52 weeks. The beta is 0.93, so SLRX's price volatility has been similar to the market average.
| Beta (5Y) | 0.93 |
| 52-Week Price Change | -73.85% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 2.93 |
| Relative Strength Index (RSI) | 43.76 |
| Average Volume (20 Days) | 44,633 |
Short Selling Information
The latest short interest is 65,040, so 4.51% of the outstanding shares have been sold short.
| Short Interest | 65,040 |
| Short Previous Month | 1,528 |
| Short % of Shares Out | 4.51% |
| Short % of Float | 4.63% |
| Short Ratio (days to cover) | 0.08 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -5.22M |
| Pretax Income | -6.46M |
| Net Income | -4.99M |
| EBITDA | -5.21M |
| EBIT | -5.22M |
| Earnings Per Share (EPS) | -$6.89 |
Full Income StatementBalance Sheet
The company has $3.28 million in cash and $328,849 in debt, giving a net cash position of $2.96 million or $2.05 per share.
| Cash & Cash Equivalents | 3.28M |
| Total Debt | 328,849 |
| Net Cash | 2.96M |
| Net Cash Per Share | $2.05 |
| Equity (Book Value) | 2.92M |
| Book Value Per Share | 2.03 |
| Working Capital | 2.89M |
Full Balance SheetCash Flow
| Operating Cash Flow | -5.29M |
| Capital Expenditures | n/a |
| Free Cash Flow | -7.69M |
| FCF Per Share | -$5.33 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |